6YY-32092-02458
3 vaccinations
14 coded responses
38 check-ins
13 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 960 / CA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-28
Registered in v-safe
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-09
Survey response — day 0, dose 1MedDRA: Parosmia — Feeling: Good · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Phantom odors (fruity)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention, Rhinorrhoea, Secretion discharge — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Runny nose/mucus production, lack of concentrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-04-12
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Survey response — day 0, dose 2MedDRA: Injection site haemorrhage — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Bleeding from injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis, Injection site bruising — Feeling: Good · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Small bruise at injection site, moderate overall sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Contusion — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: Insect bite, bruise not at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-05-30
Survey response — day 28, dose 2MedDRA: Abdominal discomfort, Constipation, Diarrhoea, Dyspepsia, Flatulence, Nausea — Feeling: GoodFree text: Moderate GI upset (approx. 3 day duration) - Indigestion, nausea, painful gas (upper & lower), + minor constipation & minor diarrhea.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-06-11
- 2021-08-01
- 2021-10-29
-
2022-01-04
Dose 3 — Pfizer-BioNTech
-
2022-01-05
Survey response — days 1–6 daily, dose 3MedDRA: Injection site hypersensitivity, Insomnia, Lymphadenopathy, Musculoskeletal pain, Sunburn, Swelling, Tonsillar hypertrophy — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Moderate increased sensitivity near injection site - similar to a sunburn. Mild - Swollen lymph nodes/tonsils in neck/jaw, only on injection side. Mild- Pain and swelling in scapula area. Moderate - Insomnia.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-07
-
2022-01-08
Survey response — days 1–6 daily, dose 3MedDRA: Oral candidiasis — Feeling: FairFree text: Thrush-like symptoms in upper mouth.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Oral candidiasis — Feeling: Good · Site: PainFree text: Mild thrush-like symptoms in upper mouth (less than yesterday)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion — Feeling: GoodFree text: Mild stuffy nose (resolved)MedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
- 2022-01-18
-
2022-01-27
Survey response — day 21, dose 3MedDRA: Cough, Pre-existing disease, Respiratory tract congestion, Sneezing — Feeling: GoodFree text: Seasonal allergies - minor coughing, major sneezing, & mild congestion. Triggered immediately by mowing yard. No fever. Resolved w/o meds within a couple of hours, after allergen removed (shower).MedDRA releases: 2024-11 · check-in free text available
- 2022-02-01
- 2022-02-08
-
2022-02-17
Survey response — day 42, dose 3MedDRA: Central sleep apnoea syndrome, Glycosylated haemoglobin increased, Nasal congestion, Office visit, Pre-existing disease, Therapeutic response unexpected — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Minor/moderate nasal congestion (seasonal allergies). Central sleep apnea diagnosis reduced from severe to mild-transitional (falling asleep) due to second opinion. Slight increase in A1c. · Healthcare visit (other): Standard doctor's visit.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-22
-
2022-04-07
Survey response — 3 months, dose 3MedDRA: Mass, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Lump on head (non-injury goose egg, cause to be determined). · Healthcare visit (other): Referral to ultrasound/imaging clinicMedDRA releases: 2024-11 · check-in free text available
-
2022-04-07
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-11
- 2022-07-06
-
2023-01-04
Survey response — 12 months, dose 3MedDRA: Blood thyroid stimulating hormone increased, COVID-19, Gastrointestinal disorder, Self-medication, Unevaluable event, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-04
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-05
- 2023-01-05
- 2023-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2022-01-04 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Phantom odors (fruity)
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose/mucus production, lack of concentration
Release 8 — day 0, dose 2
Systemic reaction (other): Bleeding from injection site
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Small bruise at injection site, moderate overall sweating
Systemic reaction (other): Insect bite, bruise not at injection site
Release 8 — day 28, dose 2
Symptoms: Moderate GI upset (approx. 3 day duration) - Indigestion, nausea, painful gas (upper & lower), + minor constipation & minor diarrhea.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Moderate increased sensitivity near injection site - similar to a sunburn. Mild - Swollen lymph nodes/tonsils in neck/jaw, only on injection side. Mild- Pain and swelling in scapula area. Moderate - Insomnia.
Systemic reaction (other): Thrush-like symptoms in upper mouth.
Systemic reaction (other): Mild thrush-like symptoms in upper mouth (less than yesterday)
Systemic reaction (other): Mild stuffy nose (resolved)
Release 11 — day 21, dose 3
Symptoms: Seasonal allergies - minor coughing, major sneezing, & mild congestion. Triggered immediately by mowing yard. No fever. Resolved w/o meds within a couple of hours, after allergen removed (shower).
Release 11 — day 42, dose 3
Symptoms: Minor/moderate nasal congestion (seasonal allergies). Central sleep apnea diagnosis reduced from severe to mild-transitional (falling asleep) due to second opinion. Slight increase in A1c.
Healthcare visit (other): Standard doctor's visit.
Release 11 — 3 months, dose 3
Symptoms: Lump on head (non-injury goose egg, cause to be determined).
Healthcare visit (other): Referral to ultrasound/imaging clinic
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Blood thyroid stimulating hormone increased | · | · | ✓ |
| SD | Central sleep apnoea syndrome | · | · | ✓ |
| SD | Constipation | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dyspepsia | ✓ | ✓ | ✓ |
| SD | Flatulence | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Glycosylated haemoglobin increased | · | · | ✓ |
| SD | Mass | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Therapeutic response unexpected | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Contusion | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site haemorrhage | ✓ | ✓ | ✓ |
| SRO | Injection site hypersensitivity | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Musculoskeletal pain | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Oral candidiasis | · | · | ✓ |
| SRO | Parosmia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Secretion discharge | ✓ | ✓ | ✓ |
| SRO | Sunburn | · | · | ✓ |
| SRO | Swelling | · | · | ✓ |
| SRO | Tonsillar hypertrophy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release